{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:07:20Z","timestamp":1771474040999,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["UOAX0815 Doctoral Scholarship"],"award-info":[{"award-number":["UOAX0815 Doctoral Scholarship"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["UOAX0815"],"award-info":[{"award-number":["UOAX0815"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["UOAX0815"],"award-info":[{"award-number":["UOAX0815"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["Doctoral Scholarship and PReSS account"],"award-info":[{"award-number":["Doctoral Scholarship and PReSS account"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["Verious project and equipment grants"],"award-info":[{"award-number":["Verious project and equipment grants"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["Various equipment grants"],"award-info":[{"award-number":["Various equipment grants"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009477","name":"Lottery Health Research","doi-asserted-by":"publisher","award":["Various equipment grants"],"award-info":[{"award-number":["Various equipment grants"]}],"id":[{"id":"10.13039\/501100009477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2 diabetes mellitus is a major health concern worldwide; however, the molecular mechanism underlying its development is poorly understood. The hormone amylin is postulated to be involved, as human amylin forms amyloid in the pancreases of diabetic patients, and oligomers have been shown to be cytotoxic to \u03b2-cells. As rodent amylin is non-amyloidogenic, mice expressing human amylin have been developed to investigate this hypothesis. However, it is not possible to differentiate the effects of amylin overexpression from \u03b2-cell loss in these models. We have developed transgenic mice that overexpress [<jats:sup>25, 28, 29<\/jats:sup> triprolyl]human amylin, a non-amyloidogenic variant of amylin, designated the Line 44 model. This model allows us to investigate the effects of chronic overexpression of non-cytotoxic amylin. We characterised this model and found it developed obesity, hyperglycaemia and hyperinsulinaemia. This phenotype was associated with alterations in the expression of genes involved in the amylin, insulin and leptin signalling pathways within the brain. This included genes such as <jats:italic>c-Fos<\/jats:italic> (a marker of amylin activation); <jats:italic>Socs3<\/jats:italic> (a leptin inhibitor); and <jats:italic>Cart<\/jats:italic>, <jats:italic>Pomc<\/jats:italic> and <jats:italic>Npy<\/jats:italic> (neuropeptides that control appetite). We also examined Socs3 protein expression and phosphorylated Stat3 to determine if changes at the mRNA level would be reflected at the protein level.<\/jats:p>","DOI":"10.1038\/s41598-019-51088-x","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T10:32:32Z","timestamp":1570703552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Altered metabolic gene expression in the brain of a triprolyl-human amylin transgenic mouse model of type 2 diabetes"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-6918","authenticated-orcid":false,"given":"Tina","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-7043","authenticated-orcid":false,"given":"Shaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greeshma","family":"Vazhoor Amarsingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-2199","authenticated-orcid":false,"given":"Mark J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-3163","authenticated-orcid":false,"given":"Garth J. S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"51088_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova, K. et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128, 40\u201350, https:\/\/doi.org\/10.1016\/j.diabres.2017.03.024 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"51088_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","volume":"148","author":"FM Ashcroft","year":"2012","unstructured":"Ashcroft, F. M. & Rorsman, P. Diabetes mellitus and the beta cell: the last ten years. Cell 148, 1160\u20131171, https:\/\/doi.org\/10.1016\/j.cell.2012.02.010 (2012).","journal-title":"Cell"},{"key":"51088_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn, S. E. et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39, 634\u2013638 (1990).","journal-title":"Diabetes"},{"key":"51088_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","volume":"100","author":"CS Potes","year":"2010","unstructured":"Potes, C. S. & Lutz, T. A. Brainstem mechanisms of amylin-induced anorexia. Physiol. Behav. 100, 511\u2013518, https:\/\/doi.org\/10.1016\/j.physbeh.2010.03.001 (2010).","journal-title":"Physiol. Behav."},{"key":"51088_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainres.2010.03.114","volume":"1334","author":"CS Potes","year":"2010","unstructured":"Potes, C. S., Lutz, T. A. & Riediger, T. Identification of central projections from amylin-activated neurons to the lateral hypothalamus. Brain Res. 1334, 31\u201344, https:\/\/doi.org\/10.1016\/j.brainres.2010.03.114 (2010).","journal-title":"Brain Res."},{"key":"51088_CR6","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1210\/en.2006-0393","volume":"147","author":"JD Roth","year":"2006","unstructured":"Roth, J. D., Hughes, H., Kendall, E., Baron, A. D. & Anderson, C. M. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 147, 5855\u20135864, https:\/\/doi.org\/10.1210\/en.2006-0393 (2006).","journal-title":"Endocrinology"},{"key":"51088_CR7","doi-asserted-by":"publisher","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","volume":"293","author":"C Mack","year":"2007","unstructured":"Mack, C. et al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1855\u20131863, https:\/\/doi.org\/10.1152\/ajpregu.00297.2007 (2007).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"51088_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton, B. & Cooper, G. J. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335, 632\u2013635, https:\/\/doi.org\/10.1038\/335632a0 (1988).","journal-title":"Nature"},{"key":"51088_CR9","doi-asserted-by":"publisher","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","volume":"86","author":"AN Roberts","year":"1989","unstructured":"Roberts, A. N. et al. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc. Natl. Acad. Sci. USA 86, 9662\u20139666 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51088_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","volume":"2","author":"A Clark","year":"1987","unstructured":"Clark, A. et al. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 2, 231\u2013234 (1987).","journal-title":"Lancet"},{"key":"51088_CR11","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper, G. J. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84, 8628\u20138632 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51088_CR12","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00125-010-1715-y","volume":"53","author":"GJ Cooper","year":"2010","unstructured":"Cooper, G. J., Aitken, J. F. & Zhang, S. Is type 2 diabetes an amyloidosis and does it really matter (to patients)? Diabetologia 53, 1011\u20131016, https:\/\/doi.org\/10.1007\/s00125-010-1715-y (2010).","journal-title":"Diabetologia"},{"key":"51088_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2337\/db07-0849","volume":"57","author":"S Zhang","year":"2008","unstructured":"Zhang, S., Liu, H., Yu, H. & Cooper, G. J. Fas-associated death receptor signaling evoked by human amylin in islet beta-cells. Diabetes 57, 348\u2013356, https:\/\/doi.org\/10.2337\/db07-0849 (2008).","journal-title":"Diabetes"},{"key":"51088_CR14","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.2337\/db05-1672","volume":"55","author":"AV Matveyenko","year":"2006","unstructured":"Matveyenko, A. V. & Butler, P. C. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55, 2106\u20132114, https:\/\/doi.org\/10.2337\/db05-1672 (2006).","journal-title":"Diabetes"},{"key":"51088_CR15","doi-asserted-by":"publisher","first-page":"52810","DOI":"10.1074\/jbc.M308244200","volume":"278","author":"S Zhang","year":"2003","unstructured":"Zhang, S., Liu, J., Dragunow, M. & Cooper, G. J. Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1. J. Biol. Chem. 278, 52810\u201352819, https:\/\/doi.org\/10.1074\/jbc.M308244200 (2003).","journal-title":"J. Biol. Chem."},{"key":"51088_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bbamem.2018.02.020","volume":"1890","author":"S Asthana","year":"2018","unstructured":"Asthana, S., Mallick, B., Alexandrescu, A. T. & Jha, S. IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies. Biochim. Biophys. Acta. Biomembr. 1890, 1765\u20131782, https:\/\/doi.org\/10.1016\/j.bbamem.2018.02.020 (2018).","journal-title":"Biochim. Biophys. Acta. Biomembr."},{"key":"51088_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0167-4889(89)90220-6","volume":"1014","author":"GJ Cooper","year":"1989","unstructured":"Cooper, G. J. et al. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim. Biophys. Acta. 1014, 247\u2013258 (1989).","journal-title":"Biochim. Biophys. Acta."},{"key":"51088_CR18","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark, P., Engstrom, U., Johnson, K. H., Westermark, G. T. & Betsholtz, C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. USA 87, 5036\u20135040 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51088_CR19","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 7283\u20137288 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51088_CR20","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere, C. B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA 93, 3492\u20133496 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51088_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2337\/diabetes.47.5.743","volume":"47","author":"WC Soeller","year":"1998","unstructured":"Soeller, W. C. et al. Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide. Diabetes 47, 743\u2013750 (1998).","journal-title":"Diabetes"},{"key":"51088_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2337\/db09-0548","volume":"59","author":"JF Aitken","year":"2010","unstructured":"Aitken, J. F. et al. Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin\/islet amyloid polypeptide transgenic mice. Diabetes 59, 161\u2013171, https:\/\/doi.org\/10.2337\/db09-0548 (2010).","journal-title":"Diabetes"},{"key":"51088_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1096\/fj.14-251744","volume":"28","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet beta cells. FASEB J. 28, 231\u2013248, https:\/\/doi.org\/10.1096\/fj.14-251744 (2014).","journal-title":"FASEB J."},{"key":"51088_CR24","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.2337\/db06-1755","volume":"57","author":"WP Wong","year":"2008","unstructured":"Wong, W. P. et al. Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance. Diabetes 57, 2737\u20132744, https:\/\/doi.org\/10.2337\/db06-1755 (2008).","journal-title":"Diabetes"},{"key":"51088_CR25","doi-asserted-by":"crossref","unstructured":"Young, A. A. et al. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Develop. Res. 37, 231\u2013248, 10.1002\/(Sici)1098-2299(199604)37:4<231::Aid-Ddr5>3.3.Co;2-2 (1996).","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M"},{"key":"51088_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0006-8993(00)03070-5","volume":"887","author":"U Arnelo","year":"2000","unstructured":"Arnelo, U. et al. Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain. Brain Res. 887, 391\u2013398 (2000).","journal-title":"Brain Res."},{"key":"51088_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/oby.2009.187","volume":"18","author":"JL Trevaskis","year":"2010","unstructured":"Trevaskis, J. L. et al. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity 18, 21\u201326, https:\/\/doi.org\/10.1038\/oby.2009.187 (2010).","journal-title":"Obesity"},{"key":"51088_CR28","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Bruning","year":"2000","unstructured":"Bruning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122\u20132125 (2000).","journal-title":"Science"},{"key":"51088_CR29","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1172\/JCI31073","volume":"118","author":"L Koch","year":"2008","unstructured":"Koch, L. et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J. Clin. Invest. 118, 2132\u20132147, https:\/\/doi.org\/10.1172\/JCI31073 (2008).","journal-title":"J. Clin. Invest."},{"key":"51088_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1126\/science.7624778","volume":"269","author":"LA Campfield","year":"1995","unstructured":"Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546\u2013549 (1995).","journal-title":"Science"},{"key":"51088_CR31","doi-asserted-by":"publisher","unstructured":"Nie, T., Zhang, S., Vazhoor Amarsingh, G., Liu, H., Cooper, G. J. L44 mouse bodyweight, blood glucose and serum hormone data. figshare. Dataset, https:\/\/doi.org\/10.17608\/k6.auckland.8285909.v2 (2019).","DOI":"10.17608\/k6.auckland.8285909.v2"},{"key":"51088_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/jcem-60-1-13","volume":"60","author":"M Chen","year":"1985","unstructured":"Chen, M., Bergman, R. N., Pacini, G. & Porte, D. Jr. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. The Journal of clinical endocrinology and metabolism 60, 13\u201320, https:\/\/doi.org\/10.1210\/jcem-60-1-13 (1985).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"51088_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/diab.45.7.947","volume":"45","author":"E Ferrannini","year":"1996","unstructured":"Ferrannini, E. et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45, 947\u2013953 (1996).","journal-title":"Diabetes"},{"key":"51088_CR34","doi-asserted-by":"publisher","first-page":"3127S","DOI":"10.1093\/jn\/130.12.3127S","volume":"130","author":"SK Fried","year":"2000","unstructured":"Fried, S. K., Ricci, M. R., Russell, C. D. & Laferrere, B. Regulation of leptin production in humans. J. Nutr. 130, 3127S\u20133131S (2000).","journal-title":"J. Nutr."},{"key":"51088_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1210\/en.2007-1307","volume":"149","author":"AS Metlakunta","year":"2008","unstructured":"Metlakunta, A. S., Sahu, M. & Sahu, A. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB\/N mice. Endocrinology 149, 1121\u20131128, https:\/\/doi.org\/10.1210\/en.2007-1307 (2008).","journal-title":"Endocrinology"},{"key":"51088_CR36","doi-asserted-by":"publisher","first-page":"R623","DOI":"10.1152\/ajpregu.00791.2009","volume":"299","author":"CS Potes","year":"2010","unstructured":"Potes, C. S. et al. Noradrenergic neurons of the area postrema mediate amylin\u2019s hypophagic action. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R623\u2013631, https:\/\/doi.org\/10.1152\/ajpregu.00791.2009 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"51088_CR37","doi-asserted-by":"publisher","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","volume":"281","author":"T Riediger","year":"2001","unstructured":"Riediger, T., Schmid, H. A., Lutz, T. & Simon, E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1833\u20131843 (2001).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"51088_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2007.06.016","volume":"1162","author":"C Becskei","year":"2007","unstructured":"Becskei, C., Grabler, V., Edwards, G. L., Riediger, T. & Lutz, T. A. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK. Brain Res. 1162, 76\u201384, https:\/\/doi.org\/10.1016\/j.brainres.2007.06.016 (2007).","journal-title":"Brain Res."},{"key":"51088_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000084488","volume":"5","author":"B Isaksson","year":"2005","unstructured":"Isaksson, B. et al. Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis. Pancreatology 5, 29\u201336, https:\/\/doi.org\/10.1159\/000084488 (2005).","journal-title":"Pancreatology"},{"key":"51088_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1113\/jphysiol.2002.018671","volume":"541","author":"S Eiden","year":"2002","unstructured":"Eiden, S., Daniel, C., Steinbrueck, A., Schmidt, I. & Simon, E. Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents. J. Physiol. 541, 1041\u20131048 (2002).","journal-title":"J. Physiol."},{"key":"51088_CR41","first-page":"E156","volume":"267","author":"TR Pieber","year":"1994","unstructured":"Pieber, T. R., Roitelman, J., Lee, Y., Luskey, K. L. & Stein, D. T. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am. J. Physiol. 267, E156\u2013164 (1994).","journal-title":"Am. J. Physiol."},{"key":"51088_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","volume":"15","author":"S Enoki","year":"1992","unstructured":"Enoki, S. et al. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 15, 97\u2013102 (1992).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"51088_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1124\/mol.56.1.235","volume":"56","author":"G Christopoulos","year":"1999","unstructured":"Christopoulos, G. et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56, 235\u2013242 (1999).","journal-title":"Mol. Pharmacol."},{"key":"51088_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cmet.2012.10.019","volume":"16","author":"AE Mehran","year":"2012","unstructured":"Mehran, A. E. et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16, 723\u2013737, https:\/\/doi.org\/10.1016\/j.cmet.2012.10.019 (2012).","journal-title":"Cell Metab."},{"key":"51088_CR45","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","volume":"15","author":"H Mulder","year":"1995","unstructured":"Mulder, H. et al. Islet amyloid polypeptide (amylin) is expressed in sensory neurons. J. Neurosci. 15, 7625\u20137632 (1995).","journal-title":"J. Neurosci."},{"key":"51088_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1096\/fj.11-191841","volume":"26","author":"ER Szabo","year":"2012","unstructured":"Szabo, E. R., Cservenak, M. & Dobolyi, A. Amylin is a novel neuropeptide with potential maternal functions in the rat. FASEB J. 26, 272\u2013281, https:\/\/doi.org\/10.1096\/fj.11-191841 (2012).","journal-title":"FASEB J."},{"key":"51088_CR47","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.neuroscience.2010.06.001","volume":"169","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity. Neurosci. 169, 1662\u20131671, https:\/\/doi.org\/10.1016\/j.neuroscience.2010.06.001 (2010).","journal-title":"Neurosci."},{"key":"51088_CR48","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/35078085","volume":"411","author":"MA Cowley","year":"2001","unstructured":"Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480\u2013484, https:\/\/doi.org\/10.1038\/35078085 (2001).","journal-title":"Nature"},{"key":"51088_CR49","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.1523\/JNEUROSCI.18-23-10128.1998","volume":"18","author":"HJ Grill","year":"1998","unstructured":"Grill, H. J., Ginsberg, A. B., Seeley, R. J. & Kaplan, J. M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18, 10128\u201310135 (1998).","journal-title":"J. Neurosci."},{"key":"51088_CR50","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1172\/JCI12954","volume":"108","author":"S Obici","year":"2001","unstructured":"Obici, S. et al. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079\u20131085, https:\/\/doi.org\/10.1172\/JCI12954 (2001).","journal-title":"J. Clin. Invest."},{"key":"51088_CR51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai, A. et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434, 1026\u20131031, https:\/\/doi.org\/10.1038\/nature03439 (2005).","journal-title":"Nature"},{"key":"51088_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","volume":"13","author":"T Scherer","year":"2011","unstructured":"Scherer, T. et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183\u2013194, https:\/\/doi.org\/10.1016\/j.cmet.2011.01.008 (2011).","journal-title":"Cell Metab."},{"key":"51088_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/29993","volume":"393","author":"P Kristensen","year":"1998","unstructured":"Kristensen, P. et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72\u201376, https:\/\/doi.org\/10.1038\/29993 (1998).","journal-title":"Nature"},{"key":"51088_CR54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0304-3940(02)00151-9","volume":"323","author":"HY Li","year":"2002","unstructured":"Li, H. Y., Hwang, H. W. & Hu, Y. H. Functional characterizations of cocaine- and amphetamine-regulated transcript mRNA expression in rat hypothalamus. Neurosci. Lett. 323, 203\u2013206 (2002).","journal-title":"Neurosci. Lett."},{"key":"51088_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#","volume":"425","author":"YL Hurd","year":"2000","unstructured":"Hurd, Y. L. & Fagergren, P. Human cocaine- and amphetamine-regulated transcript (CART) mRNA is highly expressed in limbic- and sensory-related brain regions. J. Comp. Neurol. 425, 583\u2013598 (2000).","journal-title":"J. Comp. Neurol."},{"key":"51088_CR56","doi-asserted-by":"publisher","first-page":"R321","DOI":"10.1152\/ajpregu.1991.260.2.R321","volume":"260","author":"CJ Billington","year":"1991","unstructured":"Billington, C. J., Briggs, J. E., Grace, M. & Levine, A. S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260, R321\u2013327, https:\/\/doi.org\/10.1152\/ajpregu.1991.260.2.R321 (1991).","journal-title":"Am. J. Physiol."},{"key":"51088_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmet.2012.07.004","volume":"16","author":"AC Konner","year":"2012","unstructured":"Konner, A. C. & Bruning, J. C. Selective insulin and leptin resistance in metabolic disorders. Cell Metab. 16, 144\u2013152, https:\/\/doi.org\/10.1016\/j.cmet.2012.07.004 (2012).","journal-title":"Cell Metab."},{"key":"51088_CR58","doi-asserted-by":"publisher","first-page":"11582","DOI":"10.1523\/JNEUROSCI.5712-08.2009","volume":"29","author":"MB Ernst","year":"2009","unstructured":"Ernst, M. B. et al. Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J. Neurosci 29, 11582\u201311593, https:\/\/doi.org\/10.1523\/JNEUROSCI.5712-08.2009 (2009).","journal-title":"J. Neurosci"},{"key":"51088_CR59","doi-asserted-by":"publisher","first-page":"40649","DOI":"10.1074\/jbc.M007577200","volume":"275","author":"C Bjorbak","year":"2000","unstructured":"Bjorbak, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649\u201340657, https:\/\/doi.org\/10.1074\/jbc.M007577200 (2000).","journal-title":"J. Biol. Chem."},{"key":"51088_CR60","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1210\/me.2004-0353","volume":"19","author":"SL Dunn","year":"2005","unstructured":"Dunn, S. L. et al. Feedback inhibition of leptin receptor\/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol. Endocrinol. 19, 925\u2013938, https:\/\/doi.org\/10.1210\/me.2004-0353 (2005).","journal-title":"Mol. Endocrinol."},{"key":"51088_CR61","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ab.2010.02.036","volume":"401","author":"I Romero-Calvo","year":"2010","unstructured":"Romero-Calvo, I. et al. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal. Biochem. 401, 318\u2013320, https:\/\/doi.org\/10.1016\/j.ab.2010.02.036 (2010).","journal-title":"Anal. Biochem."},{"key":"51088_CR62","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1093\/nar\/gkw677","volume":"44","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data. Nucleic Acids Res. 44, e151, https:\/\/doi.org\/10.1093\/nar\/gkw677 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51088-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:34:59Z","timestamp":1671287699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51088-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51088"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51088-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14588"}}